These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23321360)

  • 21. Generic drugs: why all the fuss ... again?
    Williams RL
    Am Pharm; 1986 Sep; NS26(9):21-2, 47. PubMed ID: 3776832
    [No Abstract]   [Full Text] [Related]  

  • 22. Generic anti-arrhythmic drugs.
    Obel IW
    Cardiovasc J S Afr; 2002; 13(3):131; author reply 132-3. PubMed ID: 12193966
    [No Abstract]   [Full Text] [Related]  

  • 23. ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.
    Holmes DR; Becker JA; Granger CB; Limacher MC; Page RL; Sila C;
    J Am Coll Cardiol; 2011 Sep; 58(12):1287-307. PubMed ID: 21849242
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA reiterates warning against online drug buying.
    Rados C
    FDA Consum; 2004; 38(5):17. PubMed ID: 15595143
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioequivalence/bioavailability retention samples.
    Ransom C
    Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218
    [No Abstract]   [Full Text] [Related]  

  • 26. Generic equivalency: does it exist?
    Payne RJ
    Med Ann Dist Columbia; 1969 Sep; 38(9):490-2. PubMed ID: 5259629
    [No Abstract]   [Full Text] [Related]  

  • 27. Generic drugs. Save money--but is there a cost?
    Roberts SS
    Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comments on generic antibiotics].
    Levêque D; Gourieux B
    Med Mal Infect; 2013 Jan; 43(1):35-6. PubMed ID: 23287656
    [No Abstract]   [Full Text] [Related]  

  • 29. Making medicines safe.
    Videau JY
    Bull World Health Organ; 2001; 79(2):87. PubMed ID: 11242826
    [No Abstract]   [Full Text] [Related]  

  • 30. The generic drug approval process.
    Rheinstein PH
    Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
    [No Abstract]   [Full Text] [Related]  

  • 31. Meeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States.
    Flavin BM; Happe LE; Hatton RC
    Expert Opin Drug Saf; 2022 Feb; 21(2):167-170. PubMed ID: 34915789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic substitution: issues for problematic drugs.
    Henderson JD; Esham RH
    South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
    Heller WM
    Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
    [No Abstract]   [Full Text] [Related]  

  • 34. Generic medications: another variable in the treatment of illnesses.
    Blier P
    J Psychopharmacol; 2007 Jul; 21(5):459-60. PubMed ID: 17664245
    [No Abstract]   [Full Text] [Related]  

  • 35. An uncertain future for cardiovascular drug development?
    Garber AM
    N Engl J Med; 2009 Mar; 360(12):1169-71. PubMed ID: 19297568
    [No Abstract]   [Full Text] [Related]  

  • 36. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic bioequivalence: a scientific consensus needed.
    Am Fam Physician; 1987 Feb; 35(2):91, 95. PubMed ID: 3812175
    [No Abstract]   [Full Text] [Related]  

  • 39. Impurities in generic pharmaceutical development.
    Kovaleski J; Kraut B; Mattiuz A; Giangiulio M; Brobst G; Cagno W; Kulkarni P; Rauch T
    Adv Drug Deliv Rev; 2007 Jan; 59(1):56-63. PubMed ID: 17196702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equivalence of generic and brand-name ophthalmic products.
    Fiscella RG; Gaynes BI; Jensen M
    Am J Health Syst Pharm; 2001 Apr; 58(7):616-7. PubMed ID: 11296613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.